Genome-Scale Perturb-Seq Maps Context-Specific Regulators of Human T Cell Function
A perturb-seq study of 22 million human CD4+ T cells maps gene regulatory networks controlling T cell programs, cytokine production, age-related phenotypes, and autoimmune disease risk.
Summary
Researchers at Gladstone-UCSF and Stanford used a cutting-edge genetic screening technique called perturb-seq to systematically perturb every expressed gene across 22 million primary human CD4+ T cells. By measuring how each gene perturbation altered cell behavior — both at rest and after immune stimulation — they built a comprehensive map of gene regulatory networks controlling T cell function. The study uncovered previously unknown regulators of cytokine production and revealed that which genes are active changes dramatically depending on whether T cells are resting or stimulated. The data also identified genes linked to age-related T cell changes and to autoimmune disease risk. This resource provides a foundational toolkit for developing new therapies targeting immune aging and autoimmune conditions.
Detailed Summary
CD4+ T cells are master coordinators of immune responses, and mapping the gene networks that govern their behavior — and how those networks shift with stimulation — is central to understanding immunity, autoimmunity, and immune aging. Yet systematic regulatory mapping in primary human cells has remained challenging.
This study by Zhu, Dann, Yan, and colleagues at the Gladstone-UCSF Institute of Genomic Immunology and Stanford University deployed genome-scale perturb-seq, combining CRISPR-based gene perturbation with single-cell RNA sequencing. Every expressed gene was individually perturbed across 22 million primary human CD4+ T cells from four donors, with transcriptome-wide readouts collected in both resting and stimulated states via a novel probe-based platform.
Key findings include the identification of previously uncharacterized regulators of cytokine production — molecules central to inflammation and immune signaling. Critically, the active regulators and the gene programs they control were highly context-dependent, shifting dramatically between resting and stimulated conditions. This has major implications: interventions targeting immune regulators must account for the activation state of T cells to be effective.
The perturbation data were also used to model T cell states observed in large population-scale transcriptomic atlases, nominating specific regulators of T cell polarization and of age-related phenotypes — a direct link to immune aging biology. Additionally, the study implicated context-specific regulatory pathways in autoimmune disease risk, though the abstract does not specify which diseases.
Caveats include that findings derive from only four donors, limiting generalizability, and this summary is based on the abstract alone. Nonetheless, the dataset represents a substantial resource for decoding T cell gene regulation and its relevance to human immune traits, including aging.
Key Findings
- Genome-scale perturb-seq applied to 22 million primary human CD4+ T cells from four donors, perturbing all expressed genes in resting and stimulated conditions.
- Previously uncharacterized regulators of cytokine production were identified.
- Active gene regulatory programs shift dramatically between resting and stimulated T cell states, highlighting context-dependency.
- Perturbation signatures nominated regulators of T cell polarization and of age-related phenotypes observed in population-scale atlases.
- Context-specific gene regulatory pathways were implicated in autoimmune disease risk.
Methodology
Genome-scale perturb-seq was applied to 22 million primary human CD4+ T cells from four donors using a novel probe-based platform. Gene perturbations were performed with CRISPR, and transcriptome-wide effects were measured by single-cell RNA sequencing in both resting and stimulated conditions. Perturbation signatures were subsequently integrated with population-scale transcriptomic atlases and GWAS data for autoimmune traits.
Study Limitations
The study was conducted in CD4+ T cells from only four donors, which may limit generalizability across populations. This summary is based on the abstract only, as the full paper was not available for review; specific quantitative results, statistical thresholds, and methodological details cannot be evaluated. Findings in primary cells and transcriptomic atlases require functional validation and eventual clinical translation before therapeutic conclusions can be drawn.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
